BeOne Medicines (ONC) Share-based Compensation Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | -7.69% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | -8.89% |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -22.43% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -4.01% |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | 4.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.89% |
| Mar 31, 2026 | 29.20% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | 22.77% |
| Jun 30, 2025 | 15.44% |
| Mar 31, 2025 | 7.68% |
| Dec 31, 2024 | 15.82% |
| Sep 30, 2024 | 19.47% |
| Jun 30, 2024 | 26.38% |
| Mar 31, 2024 | 17.72% |
| Dec 31, 2023 | 18.94% |
| Sep 30, 2023 | 22.80% |
| Jun 30, 2023 | 27.14% |
| Mar 31, 2023 | 14.90% |
| Dec 31, 2022 | 23.99% |
| Sep 30, 2022 | 16.55% |
| Jun 30, 2022 | 25.49% |
| Mar 31, 2022 | 43.03% |
| Dec 31, 2021 | 27.40% |
| Sep 30, 2021 | 33.36% |